To Evaluate The Clinical Effect Of Vibhitaka Phala Churna In The Management Of Tamaka Shwash W.S.R. To Bronchial Asthama
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- 1.Relief in the symptoms of tamaka shwasa.
研究概览
简要总结
Tamaka shwasa, described in Ayurveda,is a respiratory disorder resemblingbronchial asthma.it is characterized by symptoms like wheezing, breathlessness, and coughing. The prevalence ofchronic airway disorders, particularly asthma, has increased globally, with india reporting over 30 million asthmapatients. A major concern is that many patient remain undiagnosed, and the conventional treatment involvingbronchodialators and corticosteroids often has adverse effects.Ayurveda, with its holistic approach, offers a potential solution through natural remedies. One such remedy isVibhitaka phala churna.Ayurveda mentions that vibhitaka has ability to balance the doshas, particularly kapha andvata, and provides relief from respiratory distress by acting as a vata anulomana (promoting proper vata movement)and kapha-vata hara (balancing kapha and vata doshas). It also acts as anti inflammatory, reducing mucus productionand alleviating symptoms of asthma. The chakra datta recommends the combination of Vibhitaka powder with honey(Madhu) for effective treatment of tamaka shwasa.This study aims to assess the effectiveness of Vibhitaka phala churna with madhu in managing tamaka shwasa(bronchial asthama). The study will involve 30 patients, with a treatment duration of 28 days. The dosage will be3grams of Vibhitaka powder thrice daily, mixed with honey.The anticipated outcome is to demonstrate the efficacy of this Ayurvedic formulation in alleviating asthma symptoms.Ifsuccessful, this could offer a safe and cost-effective alternative for asthma management.Assessment will be done on the basis of subjective and Objective Criteria and Investigations.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Patient fulfilling the diagnostic criteria.
- •2.Patient having intermittent, mild persistence or moderate persistent type of asthma.
- •3.Newly diagnosed patients of asthma less than 01 year.
- •4.Patient having PEFR percentage more than 40 percent.
排除标准
- •1.Pregnant or lactating woman.
- •2.Patients suffering from pathological condition like hypertension, carcinoma, left ventricular hypertrophy (LVH), ischemic heart disease (IHD), tuberculosis and diabetes mellitus.
- •3.Patients having status asthmatics and acute severe exacerbation of asthma or severe persistent asthma were excluded in the present study.
结局指标
主要结局
1.Relief in the symptoms of tamaka shwasa.
时间窗: 28 days.
2.To assess the effect of Vibhitaka Phala Churna with Madhu in the management of Tamaka shwasa,bronchial asthma.
时间窗: 28 days.
次要结局
- 1.To study the etiopathogenesis,symptomatology and progress of the disease i.e. Nidan(panchaka and predominance of dosha according to ayurvedic classics as well as modern)
